2018
DOI: 10.1002/pbc.27366
|View full text |Cite
|
Sign up to set email alerts
|

A triple‐probe FISH screening strategy for risk‐stratified therapy of acute lymphoblastic leukaemia in low‐resource settings

Abstract: Karyotyping along with a 3-probe fluorescence in situ hybridization (FISH) strategy was used to risk stratify therapy in 303 children with B-cell precursor acute lymphoblastic leukaemia. Of the 166 patients risk stratified, karyotype identified 91 (55%). FISH identified all karyotypes accurately, with the exception of hypodiploidy, and risk stratified an additional 75 patients. The frequency of ETV6-RUNX1 is lower and high hyperdiploidy, higher than reported in the west. An adapted 3-probe FISH strategy identi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 13 publications
0
11
0
Order By: Relevance
“…This higher concordance is due to an increased number of masked CG high‐hyperdiploidies identified by CEP‐based i‐FISH strategies in the above studies. In this regard, among our six FCM high‐hyperdiploid patients who were CG‐diploid, simultaneous implementation of i‐FISH CEP strategy for ploidy identification might have revealed masked high‐hyperdiploidy in at least three patients showing extra RUNX1 signals 5 . However, such reclassification was not possible in the current study as i‐FISH with CEP was not attempted to assess ploidy status.…”
Section: Discussionmentioning
confidence: 77%
See 1 more Smart Citation
“…This higher concordance is due to an increased number of masked CG high‐hyperdiploidies identified by CEP‐based i‐FISH strategies in the above studies. In this regard, among our six FCM high‐hyperdiploid patients who were CG‐diploid, simultaneous implementation of i‐FISH CEP strategy for ploidy identification might have revealed masked high‐hyperdiploidy in at least three patients showing extra RUNX1 signals 5 . However, such reclassification was not possible in the current study as i‐FISH with CEP was not attempted to assess ploidy status.…”
Section: Discussionmentioning
confidence: 77%
“…Interphase FISH (i‐FISH) strategies using centromere enumeration probes (CEP) can aid in ploidy assessment, especially in identifying masked‐hyperdiploidies (diploid by CG but hyperdiploid by FISH) and masked‐hypodiploidies (endo‐duplicated near‐haploid/low‐hypodiploid blasts misidentified as high‐hyperdiploid/near‐triploid by CG). However, i‐FISH is not sensitive enough to identify near‐haploidy, low‐hypodiploidy, and near‐triploidy 4‐7 . Due to these reasons, conventional cytogenetics, though laborious and time‐consuming, is the widely used technique to identify aneuploidies.…”
Section: Introductionmentioning
confidence: 99%
“…Cytogenetic studies include fluorescence in situ hybridization (FISH) assays for ETV6-RUNX1; BCR-ABL1; KMT2A rearrangements; iAMP21; TCF3-HLF was done for all maintenance patient whose treatment were initiated at TMC. 13 As complete cytogenetic testing by FISH is not available in Bangladesh, we did only RT-PCR method for BCR-ABL in newly diagnosed patient at our center. Only one of newly diagnosed patient had done cytogenetic studies for other translocations including t (12;21) Early treatment response was determined by prednisolone response (prednisolone good responder [PGR] and prednisolone poor responder [PPR] if they had <1000 blasts/PL in peripheral blood and >1000 blasts/PL in peripheral blood after 1 week of steroid prephase respectively) and minimal residual disease (MRD) estimation after 5 weeks of induction treatment.…”
Section: Methodsmentioning
confidence: 99%
“…cranial nerve palsies). Cytogenetic studies include fluorescence in situ hybridisation (FISH) [ 26 ] assays for recurrent gene fusions, rearrangements and amplifications ( ETV6 - RUNX1 ; BCR - ABL1 ; KMT2A rearrangements; other ABL -class rearrangements; intrachromosomal amplification of chromosome 21 [iAMP21]; TCF3 - HLF ) and screening for aneuploidies (specifically hypodiploid ALL, modal chromosome number < 40) by DNA ploidy analysis (flow cytometry) and/or conventional karyotyping. Treatment response is assessed by evaluating the prednisolone response [ 27 ] and by assessing the remission status and levels of MRD in the bone marrow following completion of the induction treatment phase.…”
Section: Interventionsmentioning
confidence: 99%